Global Tuberculosis Report -- 2012.pdf
Global Tuberculosis Report -- 2012.pdf
Global Tuberculosis Report -- 2012.pdf
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TABLE 1.2 <strong>Report</strong>ing of data in the 2012 round of global TB data collection<br />
COUNTRIES AND TERRITORIES<br />
MEMBER STATES<br />
WHO REGION OR SET OF COUNTRIES<br />
NUMBER NUMBER THAT REPORTED DATA NUMBER NUMBER THAT REPORTED DATA<br />
African Region 46 46 46 46<br />
Eastern Mediterranean Region 23 23 22 22<br />
European Region a 54 42 53 41<br />
Region of the Americas 46 46 35 35<br />
South-East Asia Region 11 11 11 11<br />
Western Pacifi c Region 36 36 27 27<br />
High-burden countries (HBCs) b 22 22 22 22<br />
WORLD 216 204 194 182<br />
a<br />
Countries that did not report by the deadlines were mostly low-incidence countries in Western Europe.<br />
b<br />
The HBCs are Afghanistan, Bangladesh, Brazil, Cambodia, China, the Democratic Republic of the Congo, Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria,<br />
Pakistan, the Philippines, the Russian Federation, South Africa, Thailand, Uganda, the United Republic of Tanzania, Viet Nam and Zimbabwe.<br />
Chapter 6, on TB diagnostics and laboratory strengthening,<br />
summarizes recent policy development and analyses<br />
laboratory capacity in 2011. The development of<br />
laboratory capacity through the EXPAND-TB project and<br />
the latest data on progress in rolling out Xpert MTB/RIF<br />
since endorsement of this rapid molecular test in 2010 are<br />
given particular attention.<br />
Chapter 7 contains the most recent data on progress<br />
in implementing collaborative TB/HIV activities to jointly<br />
address the epidemics of TB and HIV. The lives saved by<br />
these interventions since WHO policy was issued in 2004<br />
and the need to further increase the coverage of antiretroviral<br />
therapy for TB patients living with HIV are highlighted.<br />
Chapter 8 discusses research and development for new<br />
TB diagnostics, drugs and vaccines. After years of stagnation,<br />
considerable progress has occurred in the last<br />
decade and the development pipelines as of mid-2012 are<br />
described and discussed.<br />
The report also has four annexes. Annex 1 explains<br />
the methods used to produce estimates of the burden of<br />
disease caused by TB. Annex 2 contains country profiles<br />
for the 22 high-burden countries (HBCs) that collectively<br />
account for about 80% of the world’s TB cases (profiles<br />
for all countries are available online 1 ). Annex 3 contains<br />
regional profiles. Annex 4 consists of summary tables that<br />
provide data on key indicators for the world, WHO’s six<br />
regions and individual countries.<br />
1<br />
www.who.int/tb/data<br />
GLOBAL TUBERCULOSIS REPORT 2012 7